379 related articles for article (PubMed ID: 19501000)
21. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
22. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
[TBL] [Abstract][Full Text] [Related]
23. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.
Ghiringhelli F; Apetoh L; Tesniere A; Aymeric L; Ma Y; Ortiz C; Vermaelen K; Panaretakis T; Mignot G; Ullrich E; Perfettini JL; Schlemmer F; Tasdemir E; Uhl M; Génin P; Civas A; Ryffel B; Kanellopoulos J; Tschopp J; André F; Lidereau R; McLaughlin NM; Haynes NM; Smyth MJ; Kroemer G; Zitvogel L
Nat Med; 2009 Oct; 15(10):1170-8. PubMed ID: 19767732
[TBL] [Abstract][Full Text] [Related]
24. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Schweneker K; Gorka O; Schweneker M; Poeck H; Tschopp J; Peschel C; Ruland J; Gross O
Immunobiology; 2013 Apr; 218(4):664-73. PubMed ID: 22921586
[TBL] [Abstract][Full Text] [Related]
25. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.
Babelova A; Moreth K; Tsalastra-Greul W; Zeng-Brouwers J; Eickelberg O; Young MF; Bruckner P; Pfeilschifter J; Schaefer RM; Gröne HJ; Schaefer L
J Biol Chem; 2009 Sep; 284(36):24035-48. PubMed ID: 19605353
[TBL] [Abstract][Full Text] [Related]
26. Inflammasome and IL-1beta-mediated disorders.
Hoffman HM; Wanderer AA
Curr Allergy Asthma Rep; 2010 Jul; 10(4):229-35. PubMed ID: 20425006
[TBL] [Abstract][Full Text] [Related]
27. Critical role for mast cells in interleukin-1β-driven skin inflammation associated with an activating mutation in the nlrp3 protein.
Nakamura Y; Franchi L; Kambe N; Meng G; Strober W; Núñez G
Immunity; 2012 Jul; 37(1):85-95. PubMed ID: 22819042
[TBL] [Abstract][Full Text] [Related]
28. SYK kinase signaling and the NLRP3 inflammasome in antifungal immunity.
Poeck H; Ruland J
J Mol Med (Berl); 2010 Aug; 88(8):745-52. PubMed ID: 20401456
[TBL] [Abstract][Full Text] [Related]
29. Methylsulfonylmethane inhibits NLRP3 inflammasome activation.
Ahn H; Kim J; Lee MJ; Kim YJ; Cho YW; Lee GS
Cytokine; 2015 Feb; 71(2):223-31. PubMed ID: 25461402
[TBL] [Abstract][Full Text] [Related]
30. Inflammasome inhibition under physiological and pharmacological conditions.
Caseley EA; Poulter JA; Rodrigues F; ; McDermott MF
Genes Immun; 2020 Aug; 21(4):211-223. PubMed ID: 32681062
[TBL] [Abstract][Full Text] [Related]
31. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
Aróstegui JI
Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
[TBL] [Abstract][Full Text] [Related]
32. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.
Chae JJ; Cho YH; Lee GS; Cheng J; Liu PP; Feigenbaum L; Katz SI; Kastner DL
Immunity; 2011 May; 34(5):755-68. PubMed ID: 21600797
[TBL] [Abstract][Full Text] [Related]
33. Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes.
Banoth B; Sutterwala FS
J Clin Invest; 2017 Dec; 127(12):4235-4237. PubMed ID: 29130931
[TBL] [Abstract][Full Text] [Related]
34. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
Mitroulis I; Skendros P; Ritis K
Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
[TBL] [Abstract][Full Text] [Related]
35. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
[TBL] [Abstract][Full Text] [Related]
36. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes.
Guarda G; Dostert C; Staehli F; Cabalzar K; Castillo R; Tardivel A; Schneider P; Tschopp J
Nature; 2009 Jul; 460(7252):269-73. PubMed ID: 19494813
[TBL] [Abstract][Full Text] [Related]
37. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
[TBL] [Abstract][Full Text] [Related]
38. The inflammasome, an innate immunity guardian, participates in skin urticarial reactions and contact hypersensitivity.
Kambe N; Nakamura Y; Saito M; Nishikomori R
Allergol Int; 2010 Jun; 59(2):105-13. PubMed ID: 20179416
[TBL] [Abstract][Full Text] [Related]
39. The NLRP3 inflammasome in kidney disease and autoimmunity.
Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
